FSLLRY-NH2 - CAS 245329-02-6
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C39H60N10O8
Molecular Weight:
796.97
COA:
Inquire
Targets:
Protease-Activated Receptors (PARs)
Description:
FSLLRY-NH2 is a selective PAR2 peptide antagonist. It reverses taxol-induced mechanical allodynia, heat hyperalgesia and PKC activation in ICR mice, also suppresses ERK activation and collagen production in isolated cardiac fibroblasts.
Brife Description:
PAR2 antagonist
MSDS:
Inquire
InChIKey:
KMSCNWHRNILNRJ-JNRWAQIZSA-N
InChI:
InChI=1S/C39H60N10O8/c1-22(2)17-30(36(55)45-28(11-8-16-44-39(42)43)35(54)46-29(33(41)52)20-25-12-14-26(51)15-13-25)47-37(56)31(18-23(3)4)48-38(57)32(21-50)49-34(53)27(40)19-24-9-6-5-7-10-24/h5-7,9-10,12-15,22-23,27-32,50-51H,8,11,16-21,40H2,1-4H3,(H2,41,52)(H,45,55)(H,46,54)(H,47,56)(H,48,57)(H,49,53)(H4,42,43,44)/t27-,28-,29-,30-,31-,32-/m0/s1
Canonical SMILES:
CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CC2=CC=CC=C2)N
1.Aspergillus fumigatus Increased PAR-2 Expression and Elevated Proinflammatory Cytokines Expression Through the Pathway of PAR-2/ERK1/2 in Cornea.
Niu Y;Zhao G;Li C;Lin J;Jiang N;Che C;Zhang J;Xu Q Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):166-175. doi: 10.1167/iovs.17-21887.
Purpose: ;To determine the role of protease-activated receptor-2 (PAR-2) in cornea infected by Aspergillus fumigatus.;Methods: ;PAR-2 was tested in normal and infected corneas of C57BL/6 mice. Mice corneas were infected with A. fumigatus with or without pretreatment of PAR-2 antagonist (FSLLRY-NH2). Polymorphonuclear neutrophilic leukocytes (PMNs) were stimulated with 75% ethanol-killed A. fumigatus with or without pretreatment of FSLLRY-NH2. Disease severity was documented by clinical score and photographs with a slit lamp. PCR, Western blot, and ELISA tested expression of PAR-2, IL-1β, TNF-α, IFN-γ, MIP-2, and p-ERK1/2. PMN infiltration was assessed by myeloperoxidase assay and immunofluorescent staining.;Results: ;PAR-2 expression was significantly elevated by A. fumigatus, whereas the upregulation was significantly inhibited by FSLLRY-NH2 in mice corneas. FSLLRY-NH2 decreased disease response, PMN infiltration, and proinflammatory cytokine expression compared with infected control. In PMNs, PAR-2 expression was also significantly increased by A. fumigatus, which was significantly inhibited by FSLLRY-NH2. FSLLRY-NH2 significantly inhibited proinflammatory cytokine protein expression, as compared with that in infected control cells, which may be modified by p-ERK1/2.
2.Induction of IL-13 production and upregulation of gene expression of protease activated receptors in P815 cells by IL-6.
Zhang H;Lin L;Yang H;Zhang Z;Yang X;Zhang L;He S Cytokine. 2010 May;50(2):138-45. doi: 10.1016/j.cyto.2010.02.006. Epub 2010 Mar 1.
Interleukin (IL)-6 is a multifunctional cytokine which has been showed to induce up-regulated expression of Fc epsilon RI receptor and histamine production in mast cells. However, little is known of its effects on Th2 cytokine secretion and protease activated receptor (PAR) expression in mast cells. In the present study, we examined potential influence of IL-6 on IL-13, IL-4 and IL-10 release from P815 cells and PAR expression on P815 cells by using flow cytometry analysis, quantitative real-time PCR, ELISA and cellular activation of signaling ELISA (CASE) techniques. The results showed that IL-6 induced up to 1.8-fold increase in IL-13, but not IL-4 or IL-10 release from P815 cells, and FSLLRY-NH(2) did not affect IL-6 induced IL-13 release. Tryptase elicited 2.0-fold increase in IL-13 release from P815 cells, which can be inhibited by IL-6. IL-6 elicited the up-regulated expression of PAR-1, PAR-2, PAR-3 and PAR-4 mRNAs, but had little effects on expression of PAR proteins. U0126, PD98059 and LY204002 abolished IL-6 induced IL-13 release when they were preincubated with P815 cells, indicating ERK and Akt cell signaling pathways may be involved in the event. In conclusion, IL-6 can stimulate IL-13 release from mast cells through an ERK and Akt cell signaling pathway dependent, but PAR independent mechanism.
3.Inhibitory effect of FSLLRY-NH
Lee YJ;Kim SJ;Kwon KW;Lee WM;Im WJ;Sohn UD Arch Pharm Res. 2017 Jul;40(7):854-863. doi: 10.1007/s12272-017-0927-9. Epub 2017 Jun 22.
Proteinase activated receptor 2 (PAR2), which is localized in the GI tract, the respiratory system, and the kidney tubules is a G protein-coupled receptor associated with inflammation, metabolism, and disease. The aim of this study was to explore the role of PAR2 in hydrogen peroxide (H;2;O;2;)-induced HepG2 cells by using FSLLRY-NH;2; a PAR2 antagonist. H;2;O;2; treatment resulted in induction of PAR2 in esophageal, gastric, and liver cells, with the most robust response being in HepG2 cells. Furthermore, this effect was dose-dependent in HepG2 cells. Treatment with H;2;O;2; at concentrations above 400 μM for 24 h also reduced HepG2 cell viability. H;2;O;2; treatment increased both the protein and mRNA levels of IL-1β, IL-8, and TNF-α, as well as those of SAPK/JNK. The increased levels of these pro-inflammatory genes and SAPK/JNK induced by H;2;O;2; were attenuated in a dose-dependent manner when cells were co-treated with H;2;O;2; and FSLLRY-NH2. In summary, the PAR2 antagonist peptide, FSLLRY-NH2, reduces the level of the pro-inflammatory genes IL-8, IL-1β, and TNF-α induced by H;2;O;2;, through the SAPK/JNK pathways in HepG2 cells. These data suggest that a PAR2 antagonist could be an anti-inflammatory agent in HepG2 cells.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Protease-Activated Receptors (PARs) Products


CAS 190383-13-2 SLIGKV-NH2

SLIGKV-NH2
(CAS: 190383-13-2)

SLIGKV-NH2 is a protease-activated receptor 2 (PAR2) agonist (Ki = 9.64 μM; IC50 = 10.4 μM).

Atopaxar
(CAS: 751475-53-3)

Atopaxar is a Protease-activated receptor-1 (PAR-1) inhibitor. It can inhibit the binding of a high-affinity thrombin receptor-activating peptide ([(3)H]haTRAP)...

CAS 729589-58-6 2-Furoyl-LIGRLO-amide

2-Furoyl-LIGRLO-amide
(CAS: 729589-58-6)

2-Furoyl-LIGRLO-amide is a potent and selective PAR2 receptor agonist (pD2 = 7.0). It causes a dose-dependent relaxation of murine femoral arteries.

CAS 942413-05-0 VKGILS-NH2

VKGILS-NH2
(CAS: 942413-05-0)

VKGILS-NH2 is a reversed control peptide for SLIGKV-NH2, which is a protease-activated receptor 2 (PAR2) agonist.

CAS 474550-69-1 E 5555 hydrobromide

E 5555 hydrobromide
(CAS: 474550-69-1)

E 5555 hydrobromide is a potent and orally bioactive thrombin receptor (or protease-activated receptor 1, PAR1) antagonist (IC50 = 19 nM). It inhibits human pla...

CAS 171436-38-7 SLIGRL-NH

SLIGRL-NH
(CAS: 171436-38-7)

LIGRL-NH2 is a PAR2 activator with EC50 value of ~5 µM. It can be used to explore signaling through PAR2 in cells.

BMS-986141

BMS-986141 is a dual antagonist of proteinase-activated receptor 1 (PAR1) and PAR4. BMS-986141 was confirmed in cynomolgus monkeys to be a better therapy for pr...

CAS 141136-83-6 Thrombin Receptor Activator Peptide 6

Thrombin Receptor Activator Peptide 6
(CAS: 141136-83-6)

TRAP-6, a peptide compound, has been found to be a PAR1 agonist and could also influence the phosphorylation of rapid phosphodiesterase 3A in the positive way.

CAS 89159-60-4 ML 354

ML 354
(CAS: 89159-60-4)

ML 354 is a selective PAR4 antagonist with IC50 value of 140 nM.

CAS 245329-02-6 FSLLRY-NH2

FSLLRY-NH2
(CAS: 245329-02-6)

FSLLRY-NH2 is a selective PAR2 peptide antagonist. It reverses taxol-induced mechanical allodynia, heat hyperalgesia and PKC activation in ICR mice, also suppre...

CAS 1252806-86-2 GB 83

GB 83
(CAS: 1252806-86-2)

GB 83 is a selective antagonist of human protease activated receptor 2 (PAR2) (IC50 = 2 mM).

BMS-986120
(CAS: 1478712-37-6)

BMS-986120, an imidazoles derivative, has been found to be a PAR4 antagonist that could probably be effective against thrombus propagation and pathological vasc...

CAS 916170-19-9 AC-55541

AC-55541
(CAS: 916170-19-9)

AC-55541 is a novel small-molecule protease-activated receptor 2(PAR2) agonist which displays no activity at other PAR subtypes or at over 30 other receptors in...

CAS 173904-50-2 FR 171113

FR 171113
(CAS: 173904-50-2)

FR 171113 is a protease-activated receptor 1 (PAR1) antagonist displaying significant antiplatelet activity in vitro. It inhibits thrombin TRAP-6-induced platel...

CAS 327177-34-4 tcY-NH2

tcY-NH2
(CAS: 327177-34-4)

tcY-NH2 is a selective PAR4 antagonist peptide that inhibits aggregation caused by receptor-activating peptide analogs (GY-NH2, AY-NH2) and thrombin.

CAS 618385-01-6 Vorapaxar

Vorapaxar
(CAS: 618385-01-6)

SCH-530348 is a novel antiplatelet agent undergoing development by Schering-Plough Corp for the treatment and prevention of atherothrombosis. It is currently un...

CAS 1216720-69-2 SCH 79797 dihydrochloride

SCH 79797 dihydrochloride
(CAS: 1216720-69-2)

SCH 79797 dihydrochloride is a potent and selective non-peptide PAR1 receptor antagonist (IC50 = 70 nM). SCH 79797 blocks haTRAP-induced human platelet aggregat...

CAS 1051487-82-1 AC 264613

AC 264613
(CAS: 1051487-82-1)

AC 264613 is a potent and selective protease-activated receptor 2 (PAR2) agonist (pEC50 = 7.5). AC 264613 inhibits interferon regulatory factor 5 and decreases ...

CAS 245329-01-5 LRGILS-NH

LRGILS-NH
(CAS: 245329-01-5)

LRGILS-NH is a control peptide for SLIGRL-NH2, a protease-activated receptor-2 (PAR2) agonist that facilitates gastrointestinal transit in vivo.

UDM-002555

UDM-002555 is a small-molecule and selective antagonist of protease-activated receptor-4 (PAR-4). It can suppress the activation of platelet in dose manner. In ...

Chemical Structure

CAS 245329-02-6 FSLLRY-NH2

Quick Inquiry

Verification code

Featured Items